Companies / BIO

BIOME AUSTRALIA LIMITED

ASX:BIOHousehold & Personal Products
231.4M shares on issueASX (delayed) · snapshot 28 Oct 2026231.4M fully diluted+0.0% if every option and right converts$0.36price · delayed$84.5MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.
Minimal
Dilution risk

Share count grew 6% in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway12+ quarters of funding
Share-count growth (24m)5.6%
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

BIOME AUSTRALIA LIMITED increased its ordinary share count by 5.6% between September 2024 and September 2026, its latest share-count filing, to 231M shares. The company has not conducted any capital raises (placements, rights issues or share purchase plans) in the 24-month window. No options or rights overhang data is disclosed. Proposed securities issues (Appendix 3B) are none pending. Based on its September 2026 quarterly report, the company has more than 4 quarters of funding at the recent spend rate.

AI-generated summary of this page's cited filings · updated 26 Oct 2026
Quick answers · 2

How much placement capacity does BIO have left?

About 99% of the 15% placement capacity left, about 1% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much has BIO's share count grown?

Biome Australia has 231.4M shares on issue as at 28 Oct 2026, up 5.6% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get BIO alerts
Free for up to 2 companies. A daily email when BIO raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
0.0%
Options & rights overhang
0.0%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
0
Raises · last 12 months
12+ qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 231.4M per ASX (delayed) (snapshot 28 Oct 2026).
220M225M230MDec 24Nov 25Oct 26231.4M

Cash runway

12+ qtrs OURS
More than four quarters of funding at the recent spend rate.
More than three years of funding at the reported spend rate — far enough out that a dated estimate would be false precision.
$3.3M cash after burn.
FILED $3.4M cash · quarter ended 30 Sept 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.$3.4M cash at 30 Sep 2026 − $0.1M spent ($142k a quarter × 28 days) = $3.3M left → 12+ qtrsFILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
13 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 Sept 2026.
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
25 Sept 20262A · quoted issueBIO : ORDINARY FULLY PAID231.4MAppendix 2A
1 Apr 20263H · cancellationBIO : ORDINARY FULLY PAID228.0MAppendix 3H
30 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID228.0MAppendix 2A
20 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID224.5MAppendix 2A
20 Mar 20262A · quoted issueBIO : ORDINARY FULLY PAID227.0MAppendix 2A
Free account
19 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Capital raises

No equity raises in the last 24 months.
Free account
4 issues (incl. 2 exercises or conversions) on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

About 99% of the 15% placement capacity left — about 1% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-10-28). Holders passed a ratification we could not match to exactly one filing, or whose number of shares the result does not state, and shares issued with holder approval are not added to the base, so the true headroom may be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
25 June 2026Blair Vega NorfolkBuy on-market100k——$25k3Y notice
12 June 2026Geoffrey SamBuy off-market72k——$20k3Y notice
10 June 2026Blair Vega NorfolkBuy on-market100k——$27k3Y notice
Free account
11 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock BIO freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

26 Oct 2026$PQuarterly Activities & Cashflow Report
21 Oct 2026Notice of Annual General Meeting/Proxy Form
5 Oct 2026Change of Auditor
25 Sept 2026Secondary Trading Notice
25 Sept 2026Application for quotation of securities - BIO
23 Sept 2026Date of AGM and Closing Date for Director Nominations
22 Sept 2026Appendix 4G & Corporate Governance Statement
22 Sept 2026Annual Report
15 Sept 2026Biome Investor Presentation
9 Sept 2026$PNew Activated Probiotics launches for H1 FY27
27 Aug 2026$PBiome to Launch in China
26 Aug 2026$PPreliminary Final Report
29 July 2026$PQuarterly Activities & Cashflow Report
27 July 2026$PInternational Markets Presentation
27 July 2026Investor Webinar
1 July 2026$PFY26 Trading Update
26 June 2026Change of Director's Interest Notice
12 June 2026Change of Director's Interest Notice
12 June 2026Ceasing to be a substantial holder
11 June 2026Change of Director's Interest Notice

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.